$7.99
0.25% today
Nasdaq, Jul 28, 04:21 pm CET
ISIN
US78349D1072
Symbol
RXST

RxSight Inc Stock price

$7.97
-5.21 39.53% 1M
-24.53 75.48% 6M
-26.41 76.82% YTD
-37.33 82.41% 1Y
-6.86 46.26% 3Y
-8.03 50.19% 5Y
-8.03 50.19% 10Y
-8.03 50.19% 20Y
Nasdaq, Closing price Fri, Jul 25 2025
+0.03 0.38%

Key metrics

Basic
Market capitalization
$323.9m
Enterprise Value
$94.7m
Net debt
positive
Cash
$229.3m
Shares outstanding
40.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.2 | 2.0
EV/Sales
0.6 | 0.6
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
88.3%
Return on Equity
-9.8%
ROCE
-12.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$148.3m | $164.3m
EBITDA
$-33.6m | $-24.7m
EBIT
$-36.9m | $-37.0m
Net Income
$-26.6m | $-36.8m
Free Cash Flow
$-20.5m
Growth (TTM | estimate)
Revenue
46.7% | 17.4%
EBITDA
31.9% | 33.0%
EBIT
25.4% | -0.5%
Net Income
40.3% | -33.9%
Free Cash Flow
47.6%
Margin (TTM | estimate)
Gross
71.9%
EBITDA
-22.7% | -15.0%
EBIT
-24.9%
Net
-17.9% | -22.4%
Free Cash Flow
-13.8%
More
EPS
$-0.7
FCF per Share
$-0.5
Short interest
12.8%
Employees
374
Rev per Employee
$370.0k
Show more

Is RxSight Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

RxSight Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a RxSight Inc forecast:

11x Buy
65%
4x Hold
24%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a RxSight Inc forecast:

Buy
65%
Hold
24%
Sell
12%

Financial data from RxSight Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
148 148
47% 47%
100%
- Direct Costs 42 42
13% 13%
28%
107 107
66% 66%
72%
- Selling and Administrative Expenses 107 107
30% 30%
72%
- Research and Development Expense 37 37
23% 23%
25%
-34 -34
32% 32%
-23%
- Depreciation and Amortization 3.27 3.27
2,236% 2,236%
2%
EBIT (Operating Income) EBIT -37 -37
25% 25%
-25%
Net Profit -27 -27
40% 40%
-18%

In millions USD.

Don't miss a Thing! We will send you all news about RxSight Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RxSight Inc Stock News

Neutral
PRNewsWire
4 minutes ago
LOS ANGELES , July 28, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
Neutral
PRNewsWire
3 days ago
PHILADELPHIA , July 25, 2025 /PRNewswire/ -- Berger Montague PC , a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST), following the recent filing of a federal securities class action lawsuit. The lawsuit alleges that Defendants failed to disclose to investors that: (1) RxSi...
Neutral
Business Wire
3 days ago
NEW YORK--(BUSINESS WIRE)---- $RXST #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi...
More RxSight Inc News

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery The company was founded by Robert Grubbs and Daniel Schwartz on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Head office United States
CEO Ronald Kurtz
Employees 374
Founded 1997
Website www.rxsight.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today